Reinilde Heyrman

2014

In 2014, Reinilde Heyrman earned a total compensation of $734.8K as former Chief Clinical Development Officer at Bellerophon Therapeutics.

Compensation breakdown

Bonus$288,720
Option Awards$79,246
Salary$366,808
Total$734,774

Heyrman received $366.8K in salary, accounting for 50% of the total pay in 2014.

Heyrman also received $288.7K in bonus and $79.2K in option awards.

Rankings

In 2014, Reinilde Heyrman's compensation ranked 8,852nd out of 13,032 executives tracked by ExecPay. In other words, Heyrman earned more than 32.1% of executives.

ClassificationRankingPercentile
All
8,852
out of 13,032
32nd
Division
Manufacturing
3,304
out of 4,966
34th
Major group
Chemicals And Allied Products
1,122
out of 1,686
34th
Industry group
Drugs
895
out of 1,365
34th
Industry
Pharmaceutical Preparations
684
out of 1,043
34th
Source: SEC filing on April 27, 2016.

Heyrman's colleagues

We found two more compensation records of executives who worked with Reinilde Heyrman at Bellerophon Therapeutics in 2014.

2014

Jonathan Peacock

Bellerophon Therapeutics

Chief Executive Officer

2014

Martin Meglasson

Bellerophon Therapeutics

Chief Scientific Officer

You may also like